Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shinichiro Ochi
Metabolic Status and Resistin in Chronic Schizophrenia Over a 2-Year Period With Continuous Atypical Antipsychotics
Therapeutic Advances in Psychopharmacology
Related publications
Lipidomics Reveals Early Metabolic Changes in Subjects With Schizophrenia: Effects of Atypical Antipsychotics
PLoS ONE
Multidisciplinary
Metabolic Effect of Atypical Antipsychotics
Kansas Journal of Medicine
Metabolic Effects of Treatment With Atypical Antipsychotics
Journal of Clinical Psychiatry
Medicine
Psychiatry
Mental Health
Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Antipsychotic Monotherapy and Polypharmacy in the Naturalistic Treatment of Schizophrenia With Atypical Antipsychotics
BMC Psychiatry
Psychiatry
Mental Health
Costs in the Treatment of Schizophrenia in Adults Receiving Atypical Antipsychotics: An 11-Year Cohort in Brazil
Applied Health Economics and Health Policy
Medicine
Health Policy
Economics
Econometrics
Changes in Glucose and Cholesterol Levels in Patients With Schizophrenia Treated With Typical or Atypical Antipsychotics
American Journal of Psychiatry
Psychiatry
Mental Health
Erratum To: Suicidality and Second Generation Antipsychotics in Schizophrenia Patients: A Case-Controlled Retrospective Study During a 5-Year Period
Psychopharmacology
Pharmacology
Atypical Antipsychotics
PharmacoEconomics & Outcomes News